Comparison of Symbicort Single Inhaler Therapy (Symbicort Turbuhaler 160/4.5 mg, 1 Inhalation b.i.d. Plus as Needed) and Conventional Best Practice for the Treatment of Persistent Asthma in Adults - a 26-Week, Randomised, Open-Label, Parallel-Group, Multicentre Study. Study SPAIN.
Phase of Trial: Phase IV
Latest Information Update: 01 Oct 2011
At a glance
- Drugs Antiasthmatics; Budesonide/formoterol
- Indications Asthma
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 23 Feb 2010 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 17 Dec 2009 Actual patient number (791) added as reported by ClinicalTrials.gov.
- 23 Jan 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.